Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories… Read more
Market Cap & Net Worth: Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ)
Eckert & Ziegler Strahlen- und Medizintechnik AG (F:EUZ) has a market capitalization of $931.98 Million (€907.95 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #9323 globally and #1002 in its home market, demonstrating a -0.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eckert & Ziegler Strahlen- und Medizintechnik AG's stock price €14.51 by its total outstanding shares 62573961 (62.57 Million).
Eckert & Ziegler Strahlen- und Medizintechnik AG Market Cap History: 2015 to 2026
Eckert & Ziegler Strahlen- und Medizintechnik AG's market capitalization history from 2015 to 2026. Data shows growth from $262.65 Million to $931.98 Million (13.57% CAGR).
Eckert & Ziegler Strahlen- und Medizintechnik AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eckert & Ziegler Strahlen- und Medizintechnik AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
9.52x
Eckert & Ziegler Strahlen- und Medizintechnik AG's market cap is 9.52 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
84.62x
Eckert & Ziegler Strahlen- und Medizintechnik AG's market cap is 84.62 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $262.65 Million | $139.75 Million | $10.72 Million | 1.88x | 24.51x |
| 2016 | $374.57 Million | $137.94 Million | $9.55 Million | 2.72x | 39.22x |
| 2017 | $501.07 Million | $138.63 Million | $14.70 Million | 3.61x | 34.08x |
| 2018 | $868.56 Million | $168.71 Million | $16.13 Million | 5.15x | 53.84x |
| 2019 | $2.70 Billion | $178.49 Million | $22.02 Million | 15.13x | 122.64x |
| 2020 | $2.77 Billion | $176.14 Million | $22.88 Million | 15.75x | 121.25x |
| 2021 | $5.88 Billion | $180.44 Million | $34.53 Million | 32.58x | 170.26x |
| 2022 | $2.92 Billion | $222.26 Million | $29.28 Million | 13.13x | 99.68x |
| 2023 | $2.62 Billion | $246.09 Million | $26.30 Million | 10.66x | 99.73x |
| 2024 | $2.82 Billion | $295.85 Million | $33.28 Million | 9.52x | 84.62x |
Competitor Companies of EUZ by Market Capitalization
Companies near Eckert & Ziegler Strahlen- und Medizintechnik AG in the global market cap rankings as of March 19, 2026.
Key companies related to Eckert & Ziegler Strahlen- und Medizintechnik AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Eckert & Ziegler Strahlen- und Medizintechnik AG Historical Marketcap From 2015 to 2026
Between 2015 and today, Eckert & Ziegler Strahlen- und Medizintechnik AG's market cap moved from $262.65 Million to $ 931.98 Million, with a yearly change of 13.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €931.98 Million | -4.79% |
| 2025 | €978.87 Million | -65.24% |
| 2024 | €2.82 Billion | +7.36% |
| 2023 | €2.62 Billion | -10.12% |
| 2022 | €2.92 Billion | -50.36% |
| 2021 | €5.88 Billion | +111.87% |
| 2020 | €2.77 Billion | +2.75% |
| 2019 | €2.70 Billion | +210.92% |
| 2018 | €868.56 Million | +73.34% |
| 2017 | €501.07 Million | +33.77% |
| 2016 | €374.57 Million | +42.61% |
| 2015 | €262.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Eckert & Ziegler Strahlen- und Medizintechnik AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $931.98 Million USD |
| MoneyControl | $931.98 Million USD |
| MarketWatch | $931.98 Million USD |
| marketcap.company | $931.98 Million USD |
| Reuters | $931.98 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.